Literature DB >> 18238977

Vascular risk in young women with polycystic ovary and polycystic ovary syndrome.

Cesare Battaglia1, Fulvia Mancini, Arianna Cianciosi, Paolo Busacchi, Fabio Facchinetti, Giulio Reggiani Marchesini, Rebecca Marzocchi, Domenico de Aloysio.   

Abstract

OBJECTIVE: To estimate if young polycystic ovary syndrome (PCOS) patients have subclinical risks of vascular disease compared with eumenorrheic polycystic ovary (PCO) women and healthy controls.
METHODS: Twenty-eight PCOS patients, 17 eumenorrheic PCO women, and 15 healthy eumenorrheic volunteers underwent medical examination; blood measurement of nitrites/nitrates, biochemical and hormonal parameters; uteroovarian ultrasonographic analysis and color Doppler evaluation of uterine, stromal ovarian, and ophthalmic arteries; brachial artery flow-mediated vasodilatation; 24-hour ambulatory blood pressure monitoring. An oral glucose tolerance test was performed to analyze glucose, insulin, and C-peptide.
RESULTS: Doppler analysis revealed a significantly higher uterine pulsatility index in the PCOS group compared with controls. The lowest vascular resistances in the ovaries were found in PCOS and PCO compared with controls. The ophthalmic artery back pressure was significantly higher in women with PCOS than in controls. The brachial artery diameter, at baseline, was similar in all the participants. After the reactive hyperemia, a greater vasodilatation was observed in controls and PCO patients in comparison with PCOS women. Total cholesterol, triglycerides, and the atherogenic plasma index were significantly higher in PCOS than PCO and controls. Leukocytes and homocysteine were slightly higher in PCOS. The nitrites/nitrates plasma levels were lower in PCOS and PCO patients compared with controls. The insulin and C-peptide plasma values were higher in PCOS patients than controls. In PCOS patients the different estimates of insulin sensitivity and pancreatic beta-cell function were higher compared with PCO and controls.
CONCLUSION: Polycystic ovary syndrome is a condition associated with an increased vascular risk. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18238977     DOI: 10.1097/01.AOG.0000296657.41236.10

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Elevated testosterone levels during rat pregnancy cause hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in uterine arteries.

Authors:  Vijayakumar Chinnathambi; Chellakkan S Blesson; Kathleen L Vincent; George R Saade; Gary D Hankins; Chandra Yallampalli; Kunju Sathishkumar
Journal:  Hypertension       Date:  2014-05-19       Impact factor: 10.190

2.  Elevated Testosterone Reduces Uterine Blood Flow, Spiral Artery Elongation, and Placental Oxygenation in Pregnant Rats.

Authors:  Kathirvel Gopalakrishnan; Jay S Mishra; Vijayakumar Chinnathambi; Kathleen L Vincent; Igor Patrikeev; Massoud Motamedi; George R Saade; Gary D Hankins; Kunju Sathishkumar
Journal:  Hypertension       Date:  2016-01-18       Impact factor: 10.190

3.  Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.

Authors:  Marco Matteo Ciccone; Stefano Favale; Anish Bhuva; Pietro Scicchitano; Vito Caragnano; Cristina Lavopa; Giovanni De Pergola; Giuseppe Loverro
Journal:  Vasc Health Risk Manag       Date:  2009-06-29

4.  Evaluation of homocysteine levels in patients with polycystic ovarian syndrome.

Authors:  Saghar Salehpour; Ozra Manzor-Al-Ajdad; Elham Neisani Samani; Alireza Abadi
Journal:  Int J Fertil Steril       Date:  2011-02-20

5.  The Investigation of Polymorphisms in DNA Repair Genes (XRCC1, APE1 and XPD) in Women with Polycystic Ovary Syndrome

Authors:  Gonca Gulbay; Elif Yesilada; Onder Celik; Saim Yologlu
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

6.  Cigarette smoking and cardiovascular risk in young women with polycystic ovary syndrome.

Authors:  Elena Morotti; Bruno Battaglia; Raffaella Fabbri; Roberto Paradisi; Stefano Venturoli; Cesare Battaglia
Journal:  Int J Fertil Steril       Date:  2013-12-22

Review 7.  Association between High Serum Homocysteine Levels and Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Yuming Meng; Xiang Chen; Zheng Peng; Xuexiang Liu; Yifan Sun; Shengming Dai
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

8.  The Role of C-Peptide as Marker of Cardiometabolic Risk in Women With Polycystic Ovary Syndrome: A Controlled Study.

Authors:  Sebastiao Freitas de Medeiros; Laura Camila Antunes Angelo; Matheus Antonio Souto de Medeiros; Camila Regis Banhara; Bruna Barcelo Barbosa; Marcia Marly Winck Yamamoto
Journal:  J Clin Med Res       Date:  2018-01-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.